Indo Amines Limited AI Stock Analysis
Want to see IN:INDOAMIN full AI Analyst Report?
Indo Amines Limited (INDOAMIN) AI Stock Analysis
Indo Amines Limited
(NSE:INDOAMIN)
The score is primarily held back by weak cash-flow quality (negative free cash flow in FY2025–FY2026) despite improved profitability and solid ROE. Technicals show a strong uptrend but overbought momentum (RSI ~74.6) adds near-term risk. Valuation is supportive with a moderate P/E (~12.9), though the low dividend yield offers limited income support.
Indo Amines Limited (INDOAMIN) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 10.39B
- Dividend Yield
- 0.43%
- Average Volume (3M)
- 24.92K
- Price to Earnings (P/E)
- 10.4
- Beta (1Y)
- 1.45
- Revenue Growth
- 13.23%
- EPS Growth
- 22.22%
- Country
- India
- Employees
- 619
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Indo Amines Limited Business Overview & Revenue Model
Company Description
Indo Amines Limited operates as a global manufacturer and supplier, focusing on the development and production of a comprehensive range of chemicals, including fine, specialty, performance, and perfumery chemicals, alongside active pharmaceutical ing...
How the Company Makes Money
Indo Amines Limited makes money mainly by manufacturing and selling amines and amine-based specialty/intermediate chemicals to other businesses. Revenue is generated through (1) sale of manufactured chemical products: the company produces amines and...
Indo Amines Limited Financial Statement Overview
Summary
Profitability and returns improved in FY2026 (net margin ~6.8%, operating margin ~8.7%, ROE ~20.2%) and leverage is moderate with a better debt-to-equity trend (~0.79). However, cash conversion is a major drag: free cash flow was negative in FY2025 and FY2026 (about -0.22B each year) and operating cash flow is uneven, increasing funding/working-capital risk.
Income Statement
74PositiveBalance Sheet
66PositiveCash Flow
42Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.47B | 11.60B | 10.79B | 9.40B | 9.41B | 7.79B |
| Gross Profit | 3.37B | 3.04B | 2.75B | 2.20B | 2.30B | 1.91B |
| EBITDA | 1.57B | 1.23B | 1.16B | 936.55M | 913.41M | 604.51M |
| Net Income | 812.40M | 793.26M | 558.95M | 428.13M | 408.75M | 230.47M |
Balance Sheet | ||||||
| Total Assets | 0 | 8.97B | 7.79B | 6.33B | 5.97B | 5.54B |
| Cash, Cash Equivalents and Short-Term Investments | 237.05M | 237.05M | 167.79M | 55.89M | 60.73M | 61.66M |
| Total Debt | 0 | 3.11B | 2.84B | 2.17B | 2.32B | 2.07B |
| Total Liabilities | -3.94B | 5.04B | 4.61B | 3.70B | 3.71B | 3.67B |
| Stockholders Equity | 3.94B | 3.92B | 3.17B | 2.63B | 2.25B | 1.87B |
Cash Flow | ||||||
| Free Cash Flow | -81.70M | -220.64M | -216.82M | 391.02M | -109.75M | -242.71M |
| Operating Cash Flow | 363.28M | 563.71M | 697.01M | 696.71M | 203.63M | 154.59M |
| Investing Cash Flow | -375.71M | -718.75M | -904.58M | -265.64M | -298.27M | -388.40M |
| Financing Cash Flow | 66.32M | 225.81M | 153.96M | -408.70M | 40.26M | 319.15M |
Indo Amines Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDOAMIN, the sentiment is Negative. The current price of 117.00 is below the 20-day moving average (MA) of 126.15, below the 50-day MA of 132.42, and below the 200-day MA of 121.84, indicating a bearish trend. The MACD of -5.08 indicates Positive momentum. The RSI at 37.46 is Neutral, neither overbought nor oversold. The STOCH value of 14.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDOAMIN.
Indo Amines Limited Peers Comparison
Overall Rating
IN:INDIAGLYCO64Neutral
IN:VALIANTORG63Neutral
IN:AMNPLST62Neutral
IN:INDOAMIN62Neutral
IN:PRIMO59Neutral
IN:DMCC53Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 64Neutral | INR 20.86B | 6.29 | ― | 0.83% | 12.01% | 23.71% | |
| 63Neutral | INR 10.18B | 15.44 | ― | ― | 21.32% | 175.87% | |
| 62Neutral | INR 9.88B | 20.34 | ― | 0.28% | -5.09% | 12.63% | |
| 62Neutral | INR 8.49B | 10.40 | ― | 0.43% | 13.23% | 22.22% | |
| 59Neutral | INR 5.13B | 32.75 | ― | ― | -2.70% | -15.41% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 6.18B | 16.33 | ― | 1.00% | 72.14% | 34.49% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:INDOAMIN | Indo Amines Limited | 117.00 | -14.17 | -10.80% | |
| IN:AMNPLST | Amines & Plasticizers Ltd. | 179.50 | -20.00 | -10.03% | |
| IN:DMCC | DMCC Speciality Chemicals Limited | 247.70 | -31.84 | -11.39% | |
| IN:INDIAGLYCO | India Glycols Limited | 311.15 | 85.63 | 37.97% | |
| IN:PRIMO | Primo Chemicals Limited | 21.18 | -1.43 | -6.32% | |
| IN:VALIANTORG | Valiant Organics Limited | 363.30 | 77.45 | 27.09% |
Indo Amines Limited Corporate Events
Indo Amines halts Mahad plant after fatal gas leak incident
Indo Amines Limited has reported a gas leakage incident at its Mahad manufacturing facility in Raigad, Maharashtra, on 15 August 2026, which resulted in the death of one company worker and a person from a neighbouring industrial unit, while others in...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 06, 2026
